The development of antiviral drugs is still in its infancy with rapid changes and progressive milestones encountered almost daily. By the time this book is distributed, new drugs may have already been added. This is particularly true for the antiretroviral drugs, which seem to be growing in number exponentially to the casual observer trying to keep abreast of recent advances in this field. As